Do the benefits of alendronate for premenopausal women on high-dose glucocorticoids outweigh the risks?

W.F. Lems, PP Geusens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)74-75
JournalNature Clinical Practice Rheumatology
Volume5
Issue number2
DOIs
Publication statusPublished - 2009

Cite this